IBRI Chief Steps Down, Takes New Role

Posted: Updated:
Rainer Fischer was named CEO of the IBRI in October 2017. Rainer Fischer was named CEO of the IBRI in October 2017.
INDIANAPOLIS -

The Indiana Biosciences Research Institute has announced Chief Executive Officer and Chief Scientific and Innovation Officer Rainer Fischer has stepped down from both roles. The institute says Fischer, who came to Indianapolis in 2017, will remain as a senior executive for innovation and discovery. The IBRI did not provide a reason for Fischer's decision to step down.

In his new role, Fischer will work to attract new partners for sponsored and contract research, as well as new donors and grant-makers. The institute says he will also continue to build out research labs at Purdue University as part of the presidential fellowship and research professorship he received from the university last year.

"My first love is science, particularly research and development, and facilitating the scientific and funding partnerships necessary to yield meaningful and major discoveries," Fischer said in a news release. "In this more focused scientific and discovery role, I will be even more effective in helping to grow the IBRI’s partnerships, funding and talent.”

Fischer was named the CSIO of the institute in October 2016 and began the role the following April. In October 2017, he was named CEO following the departure of the institute's founding CEO, David Broecker.

"We’re grateful for Dr. Fischer’s service in these dual roles, which included broadening the IBRI’s diabetes research and expanding our focus to include the newly created Pharmaceutical Biotechnology Center," said Dan Evans, chairman of the board for the IBRI. "We have initiated a search to find a CEO who will support Dr. Fischer and the entire IBRI team with the leadership, vision and capabilities necessary to maintain our growth. During this time, we expect to conduct business as usual with no disruptions in research or operations."

The IBRI did not provide a time frame for choosing Fischer's successor. 

  • Perspectives

    • Take Time to Face Reality

      When is the last time that you as a business owner truly stopped for 30 minutes or an hour and truly took some quiet time to reflect on your business? Like most owners, it’s probably been quite some time. We all get busy doing things, working hard, taking care of customers, running the business. But if we don’t take some time each day, week, month or quarter to slow down, we are setting ourselves up for failure. Business leaders and owners need the time to slow down to...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (Image provided by the Capital Improvement Board.)

      Indy Alters Plans for Downtown Hotels

      The city of Indianapolis has announced plans to change the framework for a major project in downtown Indy that has sparked controversy. The $120 million project, announced in October 2018, calls for an expansion of the Indiana Convention Center and two new hotels at Pan Am Plaza, which would add about 1,400 rooms. The project has drawn criticism from a group of hoteliers, who have expressed concern of a potential oversaturation in downtown Indy. Indianapolis Mayor Joe Hogsett issued...

    • (Photo Courtesy: Roche Diagnostics)

      Roche VP on List of Influential Women Executives

      An executive with Roche Diagnostics has joined an exclusive list of prominent and influential women, including Oprah Winfrey and Serena Williams.  Cindy Carlisle, Vice President of Human Resources at Roche Indy, was named to Savoy Magazine’s 2019 Most Influential Women in Corporate America. 

    • Shelly Timmons

      IU Health Names New Leader of Neurosurgery

      The Indiana University School of Medicine and IU Health Physicians have named Shelly Timmons to lead the department of neurosurgery. She previously served at Penn State Health Milton S. Hershey Medical Center as vice chair for administration in the department of neurosurgery and director of neurotrauma.  

    • Bank of America Merrill Lynch Adds Mar

      Bank of America Merrill Lynch has named Lucia Mar as senior vice president and the newly created position of Indiana market executive for Global Commercial Banking. She most recently served as market manager for the Greater Tennessee market in business banking. Prior to becoming a market manager, Mar was a senior relationship manager with the healthcare and institutions team.

    • Elanco is headquartered in Greenfield.

      Elanco Finishes Deal on Pet Therapeutics Purchase

      Greenfield-based Elanco Animal Health Inc.(NYSE: ELAN) completed its purchase Thursday of Aratana Therapeutics (Nasdaq: PETX), a pet therapeutics company located near Kansas City. As Inside INdiana Business first reported Tuesday Aratana shareholders voted overwhelmingly in favor of the $245 million deal.